Navigation Links
Cadus Reports Third Quarter 2007 Results
Date:11/13/2007

NEW YORK, Nov. 13 /PRNewswire-FirstCall/ -- Cadus Corporation (OTC Bulletin Board: KDUS.OB) announced today financial results for the third quarter ended September 30, 2007.

Revenues were $0 for the third quarter of 2007 and for the same period in 2006. Net income for the third quarter of 2007 was $240,227, compared to net income of $200,335 for the same period in 2006. Basic net income per share was $0.02 for the third quarter of 2007 and for the same period in 2006.

Revenues were $100,000 for the first nine months of 2007 and for the same period in 2006. Net loss for the first nine months of 2007 was $99,282, compared to net income of $376,533 for the same period in 2006. Basic net loss per share for the first nine months of 2007 was $0.01, compared to basic net income per share for the same period in 2006 of $0.03.

As of October 31, 2007, Cadus had 13,144,040 shares outstanding.

This press release may contain forward-looking statements that involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in the company's annual report on Form 10-K for the year ended December 31, 2006. These include risks and uncertainties relating to the company's ability to license its technologies to third parties, the company's capital needs and uncertainty of future funding, the company's history of operating losses, the unpredictability of patent protection and the risk of obsolescence of the company's technologies.

CADUS CORPORATION

Condensed Consolidated Balance Sheets

ASSETS

September 30, December 31,

2007 2006

(Unaudited) (Audited)

Current assets: <
'/>"/>

SOURCE Cadus Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. QMed, Inc. Reports July Medicare SNP Enrollments
3. Phlo Affiliate Reports Expanded Coverage to Oregon Border
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
6. Carrington Reports Second Quarter 2007 Results
7. Avitar Reports Third Quarter Financial Results for Fiscal 2007
8. Response Genetics Reports Second Quarter 2007 Financial Results
9. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
10. Transgenomic, Inc. Reports Second Quarter 2007 Results
11. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... , KING OF PRUSSIA, Pa., Nov. 30 /PRNews...company specializing in interactive marketing ser...oday announced the launch of its HATCH Consulting...hatch ). Aligning strategic experts across a rang...ng, the HATCH Consulting team is committed to guid...
(Date:11/30/2009)... , BRIARCLIFF MANOR, N.Y., Nov. 30 /PRNews... guidance document for the publication of company-...ine today by the British Medical Journal (BMJ). "T...n of the importance of providing support and guida...ation of study results in the peer-reviewed medica...
(Date:11/30/2009)... , ROCKVILLE, Md., Nov. 30 /PRNewswire-FirstCal...ay it has completed enrollment in the Phase II cli...008/2009 recommended strains) VLP vaccine candidat...r adults). This randomized, double-blind, active-...lity and immunogenicity of two different doses (15...
(Date:11/30/2009)... , BOSTON and COPENHAGEN, Nov. 30 /PRNewswire/...unced today that the Harvard Medical School ICCB-L...nized as a MicroRNA Screening Center of Excellence...l School, and associated hospitals and institution... and RNAi libraries. ,, MicroRNAs are a novel c...
Breaking Biology Technology:Cadient Interactive Announces the Launch of HATCH Consulting Services 2Cadient Interactive Announces the Launch of HATCH Consulting Services 3ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ 2ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 4Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3
...ne Baird Venture Partners , the U.S. venture fu...wed up on its presence in China by partnering with... Inc. , to serve portfolio companies as they estab...wing interview with WTN, Paul Carbone, managing pa...ird Private Equity Group, explained the venture fu...
...n, Wis. - Deltanoid Pharmaceuticals , a privatel...s begun a Phase 2 clinical study of 2MD, its lead ...cted to determine whether 2MD can safely improve b...porosis, a disease caused by the loss of normal bo...curs frequently in postmenopausal women and elderl...
...n, Wis. - Dr. Leroy Hood, a prominent molecular b...oard of directors of NimbleGen Systems , a Madiso...nd president of the Seattle-based Institute for S...en,s scientific advisory board. , ,A former profe...lifornia Institute of Technology , Hood gained not...
Other Biology Technology:Visions: Carbone bullish on Wisconsin venture capital 2Visions: Carbone bullish on Wisconsin venture capital 3Visions: Carbone bullish on Wisconsin venture capital 4Visions: Carbone bullish on Wisconsin venture capital 5
(Date:11/30/2009)...nstitute, the University of Connecticut Health Cen...tate-of-the-art technology to elucidate the molecu...ium which causes syphilis. The previously unknown ...n in three dimensions. This provides the first rea...nown features, which may help fight the spread of ...
(Date:11/30/2009)...ntal Biology are pleased to announce that Dr Xavi...entifique (CNRS) in the Universit de Nice-Sophia-A...nding Paper Prize. ,The prize is awarded in recogn...d to encourage young scientists, says Hans Hopple...truly appreciate when authors submit their very be...
(Date:11/30/2009)... virus,s exquisite specialisation for its human ho...ke the humble lab mouse, can deliver only limited ... BioMed Central,s open access Journal of Biology ... creating a mouse that has key features of HIV inf... Kassiotis, from the Division of Immunoregulation ...
Breaking Biology News(10 mins):Scientists gain new understanding of disease-causing bacteria 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4A reductionist approach to HIV research 2Beyond genomics biologists and engineers decode the next frontier 10806 1Beyond genomics biologists and engineers decode the next frontier 10806 2Beyond genomics biologists and engineers decode the next frontier 10806 3TGen Drug Development establishes European footprint 10804 1TGen Drug Development establishes European footprint 10804 2Many pregnant women avoid HIV screening in Africa 10802 1
...AHASSEE, Fla. -- A commonly recognized gene that p... discriminate between blacks and whites, according..., FSU Psychology Professor Natalie Sachs-Ericsson...at the gene APOE epsilon 4 allele is a risk factor...w, it has been a mainstream belief that the gene i...
... person develops a sore or a boil, it erupts, draw...tion. Then it resolves and flattens into the skin,...ar scenario plays out in the blood vessels. Howeve...se the ability of blood vessels to recover from i...rteries can result, said researchers at Baylor Col...
...f you eat right and exercise regularly, chances ar...stroke. But thanks to new findings by researchers ...t in your favor. Two unrelated studies recently pu...ww.fasebj.org ) describe findings on atheroscleros...es. , Both studies involved experiments in mice, ...
Other Biology News:Known genetic risk for Alzheimer's in whites also places blacks at risk 2Failure to bridle inflammation spurs atherosclerosis 2New discoveries from Harvard and Baylor get to the heart of cardiovascular disease 2New discoveries from Harvard and Baylor get to the heart of cardiovascular disease 3
Mouse Anti-Aggrecan xxPEN Monoclonal Antibody, Unconjugated, Clone BC-4 from Abcam
...lar screening, low melting point agarose where sep...commended for separation of nucleic acids less tha...se is also suited to capillary electrophoresis but...3% concentration, Micro ABgarose gels are able to ...
Rabbit Anti-Nck alpha Polyclonal Antibody, Unconjugated from Abcam
Sheep Anti-Salmonella Thomasville Polyclonal Antibody, Unconjugated from Abcam
Biology Products: